180 related articles for article (PubMed ID: 1665732)
1. Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors.
McKnight AT; Maguire JJ; Elliott NJ; Fletcher AE; Foster AC; Tridgett R; Williams BJ; Longmore J; Iversen LL
Br J Pharmacol; 1991 Oct; 104(2):355-60. PubMed ID: 1665732
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
4. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
5. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
6. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
7. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
8. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
9. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
10. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; MartÃn JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
13. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
14. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
[TBL] [Abstract][Full Text] [Related]
15. [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors.
Buck SH; Harbeson SL; Hassmann CF; Shatzer SA; Rouissi N; Nantel F; van Giersbergen PL
Life Sci; 1990; 47(10):PL37-41. PubMed ID: 2170788
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist.
Maggi CA; Patacchini R; Giuliani S; Giachetti A
Eur J Pharmacol; 1993 Mar; 234(1):83-90. PubMed ID: 8386095
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
Maggi CA; Patacchini R
Br J Pharmacol; 1992 Aug; 106(4):888-92. PubMed ID: 1327390
[TBL] [Abstract][Full Text] [Related]
19. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
[TBL] [Abstract][Full Text] [Related]
20. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]